Loading clinical trials...
Loading clinical trials...
A Pilot Study of Lopinavir/Ritonavir in Participants Experiencing Virologic Relapse on NNRTI-Containing Regimens
Conditions
Interventions
Emtricitabine/Tenofovir disoproxil fumarate
Lopinavir/Ritonavir
Locations
5
India
Y.R.G Ctr, for AIDS Research and Education (11701)
Chennai, India
University of North Carolina Lilongwe CRS (12001)
Lilongwe, Malawi
Wits HIV CRS (11101)
Johannesburg, Gauteng, South Africa
Kilimanjaro Christian Medical CRS
Moshi, Tanzania
Chiang Mai University ACTG CRS (11501)
Chiang Mai, Thailand
Start Date
January 1, 2008
Primary Completion Date
October 1, 2010
Completion Date
May 1, 2012
Last Updated
March 20, 2018
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions